Formulations based on phase transition polymers or “Sol-Gel” are an important part of our research. These formulations have the particularity to be totally liquid during manufacturing and to gel during their application, thus conferring multiple advantages.
This axis has generated many international patents and “Public/Private” collaborations through CIFRE contracts, in particular with the UNITHER PHARMACEUTICALS laboratories for many years in the field of ophthalmology.
Unither Pharmaceuticals (unither-pharma.fr)